Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 30, 2023, Tecogen Inc. (the "Company") issued a press release announcing that the Company's Board of Directors appointed Dr. Abinand Rangesh to serve as the CEO of the Company effective January 30, 2023. Dr. Rangesh will also continue to serve as the CFO of the Company. A copy of the press release is attached as Exhibit 99.01. Also on January 30, 2023 Benjamin M. Locke resigned as CEO and as a director of the Company and its affiliates effective January 30, 2023 and entered into a Consulting Agreement with the Company pursuant to which he will continue to be available for consultation with management of the Company.

The information in Exhibit 99.01 to this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits


The following exhibit relating to Item 5.02 shall be deemed to be furnished, and
not filed:
Exhibit     Description
99.01         Tecogen Press Release re Appointment of Abinand Rangesh as CEO

© Edgar Online, source Glimpses